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Atopic dermatitis (AD) is a T cell dependent chronic
relapsing inflammatory skin disorder. Cyclosporine A
(CsA) has been shown to be an effective treatment for
severe AD. We studied the effect of low-dose CsA therapy
on T cell activity and T cell differentiation in AD patients.
Using a whole blood assay we demonstrated that TcR sig-
nalling in peripheral blood T cells of CsA treated AD
patients is reduced to 42% ± 18 but not totally blocked.
Such partial inhibition of TcR signalling allowed regula-
tory T cell induction under in vitro conditions. Therefore
we asked is there an in vivo regulatory T cell induction, too.
Indeed AD patients under low-dose CsA therapy have
higher numbers and frequencies of functional regulatory
T cells compared to untreated AD patients. To evaluate the
causal connection between low-dose CsA treatment and
higher regulatory T cell numbers we studied individual
patients before and during CsA therapy. The data clearly
indicate increased numbers and frequencies of regulatory
T cells after onset of CsA therapy which remained stable
during the therapy. The therapeutic effect of low-dose CsA
therapy in AD patients could be due to both, inhibition of
T cell hyperactivity and induction of suppressor T cells.
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